β-Lactams Enhance Vancomycin Activity against Methicillin-Resistant Staphylococcus aureus Bacteremia Compared to Vancomycin Alone

Vancomycin (VAN) is often used to treat methicillin-resistant Staphylococcus aureus (MRSA) bacteremia despite a high incidence of microbiological failure. Recent in vitro analyses of β-lactams in combination with VAN demonstrated synergistic activity against MRSA. The goal of this study was to exami...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dilworth, Thomas J., Ibrahim, Omar, Hall, Pamela, Sliwinski, Jora, Walraven, Carla, Mercier, Renée-Claude
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2014
Assuntos:
Clinical Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3910806/
https://ncbi.nlm.nih.gov/pubmed/24145519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01204-13
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados